131 related articles for article (PubMed ID: 25638623)
1. Immunolocalization of surfactant protein D in the liver from infants with cholestatic liver disease.
Saka R; Yanagihara I; Sasaki T; Nose S; Takeuchi M; Nakayama M; Okuyama H
J Pediatr Surg; 2015 Feb; 50(2):297-300. PubMed ID: 25638623
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor GATA6: a novel marker and putative inducer of ductal metaplasia in biliary atresia.
Soini T; Pihlajoki M; Andersson N; Lohi J; Huppert KA; Rudnick DA; Huppert SS; Wilson DB; Pakarinen MP; Heikinheimo M
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G547-G558. PubMed ID: 29388792
[TBL] [Abstract][Full Text] [Related]
3. Morphometrical and immunohistochemical study of intrahepatic bile ducts in biliary atresia.
Yamaguti DC; Patrício FR
Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):759-65. PubMed ID: 21694599
[TBL] [Abstract][Full Text] [Related]
4. Bile duct to portal space ratio and ductal plate remnants in liver disease of infants aged less than 1 year.
Sergi C; Benstz J; Feist D; Nutzenadel W; Otto HF; Hofmann WJ
Pathology; 2008 Apr; 40(3):260-7. PubMed ID: 18428045
[TBL] [Abstract][Full Text] [Related]
5. The role of endoscopic retrograde cholangiopancreatography in infants with cholestasis.
Iinuma Y; Narisawa R; Iwafuchi M; Uchiyama M; Naito M; Yagi M; Kanada S; Otaki M; Yamazaki S; Honma T; Motoyama H; Baba Y
J Pediatr Surg; 2000 Apr; 35(4):545-9. PubMed ID: 10770378
[TBL] [Abstract][Full Text] [Related]
6. Abnormal hepatic expression of fibrillin-1 in children with cholestasis.
Lamireau T; Dubuisson L; Lepreux S; Bioulac-Sage P; Fabre M; Rosenbaum J; Desmoulière A
Am J Surg Pathol; 2002 May; 26(5):637-46. PubMed ID: 11979094
[TBL] [Abstract][Full Text] [Related]
7. Bile acids in serum and bile of infants with cholestatic syndromes.
Délèze G; Paumgartner G
Helv Paediatr Acta; 1977 Jun; 32(1):29-38. PubMed ID: 617961
[TBL] [Abstract][Full Text] [Related]
8. MR cholangiography in the evaluation of neonatal cholestasis.
Jaw TS; Kuo YT; Liu GC; Chen SH; Wang CK
Radiology; 1999 Jul; 212(1):249-56. PubMed ID: 10405749
[TBL] [Abstract][Full Text] [Related]
9. Interlobular bile duct loss in pediatric cholestatic disease is associated with aberrant cytokeratin 7 expression by hepatocytes.
Ernst LM; Spinner NB; Piccoli DA; Mauger J; Russo P
Pediatr Dev Pathol; 2007; 10(5):383-90. PubMed ID: 17929991
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of VEGF A and its receptors, VEGFR1 and VEGFR2, in the liver from patients with biliary atresia.
Edom PT; Meurer L; da Silveira TR; Matte U; dos Santos JL
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):360-8. PubMed ID: 21285868
[TBL] [Abstract][Full Text] [Related]
11. Long isoform of prolactin receptor predominates in rat intrahepatic bile ducts and further increases under obstructive cholestasis.
Bogorad RL; Ostroukhova TY; Orlova AN; Rubtsov PM; Smirnova OV
J Endocrinol; 2006 Feb; 188(2):345-54. PubMed ID: 16461560
[TBL] [Abstract][Full Text] [Related]
12. Distinct Plasma Bile Acid Profiles of Biliary Atresia and Neonatal Hepatitis Syndrome.
Zhou K; Wang J; Xie G; Zhou Y; Yan W; Pan W; Che Y; Zhang T; Wong L; Kwee S; Xiao Y; Wen J; Cai W; Jia W
J Proteome Res; 2015 Nov; 14(11):4844-50. PubMed ID: 26449593
[TBL] [Abstract][Full Text] [Related]
13. P-Selectin (CD62P) Expression in Liver Tissue of Biliary Atresia: A New Perspective in Etiopathogenesis.
Sira MM; Sira AM; Ehsan NA; Mosbeh A
J Pediatr Gastroenterol Nutr; 2015 Nov; 61(5):561-7. PubMed ID: 26102172
[TBL] [Abstract][Full Text] [Related]
14. The use of Yes-associated protein expression in the diagnosis of persistent neonatal cholestatic liver disease.
Gurda GT; Zhu Q; Bai H; Pan D; Schwarz KB; Anders RA
Hum Pathol; 2014 May; 45(5):1057-64. PubMed ID: 24746211
[TBL] [Abstract][Full Text] [Related]
15. A practical approach to the pathology of neonatal cholestatic liver disease.
Cho SJ; Kim GE
Semin Diagn Pathol; 2019 Nov; 36(6):375-388. PubMed ID: 31455583
[TBL] [Abstract][Full Text] [Related]
16. Expression of the interferon-induced Mx proteins in biliary atresia.
Al-Masri AN; Flemming P; Rodeck B; Melter M; Leonhardt J; Petersen C
J Pediatr Surg; 2006 Jun; 41(6):1139-43. PubMed ID: 16769349
[TBL] [Abstract][Full Text] [Related]
17. Differential hepatic expression of CD56 can discriminate biliary atresia from other neonatal cholestatic disorders.
Sira MM; El-Guindi MA; Saber MA; Ehsan NA; Rizk MS
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1227-33. PubMed ID: 22772093
[TBL] [Abstract][Full Text] [Related]
18. Histopathological expression of Yes-associated protein in neonatal cholestasis.
Abo-Zeinah SS; Behairy B; Hussein MH; Khedr MA; El Azab DS; Adawy NM; Zakaria HM
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):189-194. PubMed ID: 31279668
[TBL] [Abstract][Full Text] [Related]
19. Clinical Assessment of Differential Diagnostic Methods in Infants with Cholestasis due to Biliary Atresia or Non-Biliary Atresia.
Dong C; Zhu HY; Chen YC; Luo XP; Huang ZH
Curr Med Sci; 2018 Feb; 38(1):137-143. PubMed ID: 30074163
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia.
Davenport M; Gonde C; Redkar R; Koukoulis G; Tredger M; Mieli-Vergani G; Portmann B; Howard ER
J Pediatr Surg; 2001 Jul; 36(7):1017-25. PubMed ID: 11431768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
